Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 11 | 2016 | 273 | 2.610 |
Why?
|
| Granulosa Cells | 8 | 2022 | 44 | 2.220 |
Why?
|
| Ovarian Follicle | 4 | 2017 | 44 | 1.140 |
Why?
|
| Endometriosis | 3 | 2023 | 83 | 1.120 |
Why?
|
| Apoptosis | 9 | 2019 | 1568 | 1.090 |
Why?
|
| Signal Transduction | 8 | 2024 | 2157 | 0.970 |
Why?
|
| Neuregulin-1 | 3 | 2024 | 26 | 0.930 |
Why?
|
| Gonadotropins | 5 | 2022 | 27 | 0.920 |
Why?
|
| Mitochondria | 8 | 2016 | 523 | 0.840 |
Why?
|
| Cell Differentiation | 10 | 2016 | 638 | 0.770 |
Why?
|
| MicroRNAs | 7 | 2023 | 518 | 0.750 |
Why?
|
| Curcumin | 2 | 2023 | 118 | 0.690 |
Why?
|
| Stromal Cells | 2 | 2018 | 55 | 0.690 |
Why?
|
| Uterine Neoplasms | 1 | 2022 | 53 | 0.680 |
Why?
|
| Leiomyoma | 1 | 2022 | 42 | 0.680 |
Why?
|
| Endometrium | 2 | 2023 | 59 | 0.590 |
Why?
|
| Cell Survival | 4 | 2017 | 945 | 0.560 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 146 | 0.530 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 43 | 0.480 |
Why?
|
| Staurosporine | 3 | 2017 | 38 | 0.460 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 139 | 0.440 |
Why?
|
| Ovary | 4 | 2017 | 113 | 0.420 |
Why?
|
| Exosomes | 1 | 2016 | 126 | 0.420 |
Why?
|
| Caspase 3 | 7 | 2022 | 227 | 0.410 |
Why?
|
| Infertility, Female | 1 | 2014 | 24 | 0.410 |
Why?
|
| Adipocytes | 2 | 2012 | 60 | 0.410 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 120 | 0.400 |
Why?
|
| Female | 21 | 2024 | 24698 | 0.400 |
Why?
|
| Rats | 10 | 2024 | 3735 | 0.370 |
Why?
|
| Malaria | 2 | 2023 | 90 | 0.370 |
Why?
|
| Animals | 24 | 2024 | 16992 | 0.350 |
Why?
|
| Gene Silencing | 2 | 2012 | 154 | 0.350 |
Why?
|
| Ceramides | 1 | 2011 | 44 | 0.340 |
Why?
|
| Biomedical Research | 3 | 2023 | 502 | 0.330 |
Why?
|
| Cytokines | 4 | 2023 | 678 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2024 | 1766 | 0.300 |
Why?
|
| Spermatogenesis | 5 | 2011 | 161 | 0.300 |
Why?
|
| Humans | 27 | 2023 | 43102 | 0.300 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 15 | 0.280 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2008 | 20 | 0.280 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1070 | 0.280 |
Why?
|
| Stem Cells | 3 | 2022 | 152 | 0.280 |
Why?
|
| Spermatozoa | 3 | 2007 | 214 | 0.270 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 458 | 0.270 |
Why?
|
| Chlamydia Infections | 2 | 2020 | 200 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 384 | 0.270 |
Why?
|
| Follicular Atresia | 2 | 2022 | 6 | 0.260 |
Why?
|
| Organizational Policy | 2 | 2019 | 25 | 0.260 |
Why?
|
| Cell Cycle | 1 | 2008 | 346 | 0.250 |
Why?
|
| bcl-X Protein | 2 | 2017 | 27 | 0.240 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2016 | 300 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 152 | 0.220 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 436 | 0.220 |
Why?
|
| Luteal Cells | 1 | 2024 | 3 | 0.220 |
Why?
|
| Adenoviridae | 3 | 2011 | 62 | 0.220 |
Why?
|
| Cells, Cultured | 7 | 2024 | 1621 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2024 | 299 | 0.200 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 415 | 0.200 |
Why?
|
| Receptor, erbB-3 | 2 | 2024 | 17 | 0.190 |
Why?
|
| Neoplasms | 1 | 2014 | 1377 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 47 | 0.190 |
Why?
|
| Sp1 Transcription Factor | 3 | 2008 | 46 | 0.190 |
Why?
|
| Chlamydia | 2 | 2020 | 45 | 0.180 |
Why?
|
| Myometrium | 1 | 2022 | 17 | 0.180 |
Why?
|
| Mentors | 2 | 2023 | 145 | 0.180 |
Why?
|
| Organoids | 1 | 2022 | 37 | 0.180 |
Why?
|
| Cytochromes c | 3 | 2013 | 48 | 0.180 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 187 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2016 | 986 | 0.170 |
Why?
|
| Phosphoproteins | 2 | 2024 | 206 | 0.170 |
Why?
|
| Toll-Like Receptors | 1 | 2021 | 51 | 0.170 |
Why?
|
| Estrogens | 1 | 2022 | 203 | 0.170 |
Why?
|
| Inflammation | 3 | 2023 | 758 | 0.160 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 157 | 0.160 |
Why?
|
| Proteins | 1 | 2003 | 382 | 0.160 |
Why?
|
| NF-kappa B | 2 | 2023 | 358 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1019 | 0.150 |
Why?
|
| Palmitic Acid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Genitalia | 1 | 2019 | 18 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 34 | 0.150 |
Why?
|
| Peer Review, Research | 1 | 2018 | 15 | 0.150 |
Why?
|
| Leadership | 1 | 2019 | 86 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2018 | 89 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 236 | 0.140 |
Why?
|
| Follicular Fluid | 1 | 2017 | 5 | 0.140 |
Why?
|
| Cell Line | 4 | 2019 | 1410 | 0.140 |
Why?
|
| Theca Cells | 1 | 2017 | 6 | 0.140 |
Why?
|
| Endothelial Cells | 4 | 2023 | 329 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2011 | 883 | 0.130 |
Why?
|
| Culture Media | 2 | 2016 | 96 | 0.130 |
Why?
|
| Gene Expression | 3 | 2011 | 701 | 0.130 |
Why?
|
| Research Personnel | 1 | 2018 | 206 | 0.130 |
Why?
|
| Mice | 9 | 2020 | 6644 | 0.130 |
Why?
|
| Trypanosomiasis, African | 2 | 2009 | 22 | 0.130 |
Why?
|
| Protein Kinase C | 1 | 2017 | 124 | 0.130 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 12 | 0.120 |
Why?
|
| Autocrine Communication | 1 | 2016 | 12 | 0.120 |
Why?
|
| Steroids | 1 | 2016 | 45 | 0.120 |
Why?
|
| Trypanosoma brucei brucei | 2 | 2009 | 82 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 434 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 80 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 189 | 0.120 |
Why?
|
| Testosterone | 1 | 2016 | 211 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2016 | 182 | 0.110 |
Why?
|
| Genital Neoplasms, Female | 1 | 2014 | 17 | 0.100 |
Why?
|
| Hemolysis | 2 | 2023 | 60 | 0.100 |
Why?
|
| Heme | 2 | 2023 | 72 | 0.100 |
Why?
|
| Cultural Diversity | 1 | 2014 | 193 | 0.090 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 18 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 2012 | 49 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 196 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 77 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 160 | 0.090 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2011 | 10 | 0.090 |
Why?
|
| United States | 3 | 2023 | 5205 | 0.090 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 44 | 0.090 |
Why?
|
| Retinoid X Receptors | 1 | 2011 | 12 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 224 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2011 | 13 | 0.090 |
Why?
|
| Transfection | 3 | 2008 | 532 | 0.090 |
Why?
|
| Androgens | 1 | 2012 | 106 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 166 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2008 | 64 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 152 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 191 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2008 | 165 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2008 | 256 | 0.080 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2009 | 12 | 0.080 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 74 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 532 | 0.070 |
Why?
|
| Sp3 Transcription Factor | 1 | 2008 | 8 | 0.070 |
Why?
|
| Vibrio cholerae | 1 | 2009 | 105 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 526 | 0.070 |
Why?
|
| G1 Phase | 1 | 2008 | 31 | 0.070 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 34 | 0.070 |
Why?
|
| Adult | 2 | 2016 | 13872 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1124 | 0.070 |
Why?
|
| Brain | 2 | 2008 | 1472 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2008 | 126 | 0.070 |
Why?
|
| Neuroglia | 1 | 2008 | 133 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 144 | 0.060 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 22 | 0.060 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 518 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 263 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2006 | 90 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2006 | 77 | 0.060 |
Why?
|
| Adipogenesis | 1 | 2005 | 14 | 0.060 |
Why?
|
| Lentivirus | 1 | 2005 | 24 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2008 | 536 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 2005 | 37 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 307 | 0.060 |
Why?
|
| Corpus Luteum | 1 | 2024 | 4 | 0.060 |
Why?
|
| Cloning, Organism | 1 | 2004 | 22 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 121 | 0.050 |
Why?
|
| Hemopexin | 1 | 2023 | 3 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2023 | 21 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2004 | 57 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 278 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.050 |
Why?
|
| Oocytes | 1 | 2004 | 149 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 65 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 35 | 0.050 |
Why?
|
| Fertilization | 1 | 2003 | 37 | 0.050 |
Why?
|
| Epididymis | 1 | 2003 | 29 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1869 | 0.050 |
Why?
|
| Plasmodium | 1 | 2022 | 16 | 0.050 |
Why?
|
| Liposomes | 1 | 2023 | 132 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2003 | 81 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 224 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2004 | 191 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 968 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 430 | 0.050 |
Why?
|
| Chemokines | 1 | 2022 | 96 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 187 | 0.040 |
Why?
|
| Cattle | 1 | 2003 | 498 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 934 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2676 | 0.040 |
Why?
|
| Pregnancy, Ectopic | 1 | 2020 | 15 | 0.040 |
Why?
|
| Photoperiod | 1 | 2020 | 27 | 0.040 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2020 | 19 | 0.040 |
Why?
|
| Male | 7 | 2016 | 23409 | 0.040 |
Why?
|
| Chlamydia muridarum | 1 | 2020 | 104 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2021 | 171 | 0.040 |
Why?
|
| Writing | 1 | 2018 | 42 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 177 | 0.040 |
Why?
|
| Base Sequence | 2 | 2011 | 983 | 0.030 |
Why?
|
| Program Development | 1 | 2018 | 240 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1596 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2008 | 173 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 327 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 8 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2008 | 168 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 88 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 694 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 704 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1772 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1542 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 408 | 0.030 |
Why?
|
| Minority Groups | 1 | 2019 | 690 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 652 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1271 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 655 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 294 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 310 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 455 | 0.020 |
Why?
|
| Protozoan Vaccines | 1 | 2009 | 16 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2009 | 82 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 95 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 148 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 173 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2007 | 94 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 671 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 515 | 0.020 |
Why?
|
| Teratoma | 1 | 2005 | 10 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 592 | 0.010 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 49 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 65 | 0.010 |
Why?
|
| Regeneration | 1 | 2005 | 32 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 94 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2005 | 83 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 2004 | 9 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 183 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 138 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 52 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 209 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1180 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 314 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 411 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 138 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 98 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2004 | 64 | 0.010 |
Why?
|
| Brain Stem | 1 | 2004 | 52 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 79 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 148 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 1177 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 109 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 183 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 313 | 0.010 |
Why?
|